Kinetics of anthracycline accumulation in multidrug-resistant tumor cells: relationship to drug lipophilicity and serum albumin binding (Q40997228)

25 September 2017

title

Kinetics of anthracycline accumulation in multidrug-resistant tumor cells: relationship to drug lipophilicity and serum albumin binding (English)

1 reference

25 September 2017

main subject

multiple drug resistance

1 reference

Demant EJ

1

1 reference

25 September 2017

Friche E

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 November 1998

1 reference

25 September 2017

published in

Biochemical Pharmacology

1 reference

25 September 2017

volume

56

1 reference

25 September 2017

issue

9

1 reference

25 September 2017

page(s)

1209-1217

1 reference

Biochemistry of multidrug resistance mediated by the multidrug transporter

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Kinetics of the multidrug transporter (P-glycoprotein) and its reversal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Improved cellular accumulation is characteristic of anthracyclines which retain high activity in multidrug resistant cell lines, alone or in combination with verapamil or cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

The P-glycoprotein-mediated relative decrease in cytosolic free drug concentration is similar for several anthracyclines with varying lipophilicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Circumvention of P-GP MDR as a function of anthracycline lipophilicity and charge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

The influence of pH on the interaction of lipophilic anthracyclines with bovine serum albumin. Quantitative characterization by measurement of fluorescence quenching.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Comparative serum protein binding of anthracycline derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Effects of lipophilicity and protein binding on the hepatocellular uptake and hepatic disposition of two anthracyclines, doxorubicin and iododoxorubicin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Equilibrium binding of anthracycline cytostatics to serum albumin and small unilamellar phospholipid vesicles as measured by gel filtration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

In vitro circumvention of anthracycline--resistance in Ehrlich ascites tumour by anthracycline analogues.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

A model for computer simulation of P-glycoprotein and transmembrane delta pH-mediated anthracycline transport in multidrug-resistant tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Transport and binding of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Anthracycline incorporation in human lymphocytes. Kinetics of uptake and nuclear concentration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Recognition of anthracycline binding domains in bovine serum albumin and design of a free fatty acid sensor protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Determination of the osmotic active drug concentration in the cytoplasm of anthracycline-resistant and -sensitive K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Use of fluorescein isothiocyanate-dextran to measure proton pumping in lysosomes and related organelles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Carrier-mediated transport of daunorubicin, adriamycin, and rubidazone in ehrlich ascites tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Comparison of the binding of anthracycline derivatives to purified DNA and to cell nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

A Fickian diffusion transport process with features of transport catalysis. Doxorubicin transport in human red blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

DNA-containing liposomes as a model for the study of cell membrane permeation by anthracycline derivatives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Comparison of the membrane transport of anthracycline derivatives in drug-resistant and drug-sensitive K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Cellular transport of anthracyclines by passive diffusion. Implications for drug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

The role of the MDR protein in altered drug translocation across tumor cell membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Increase in nonspecific adsorptive endocytosis in anthracycline- and vinca alkaloid-resistant Ehrlich ascites tumor cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Permeability of lipid bilayer to anthracycline derivatives. Role of the bilayer composition and of the temperature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adriamycin by verapamil in living K562 leukemia cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

P-glycoprotein-mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Saturable P-glycoprotein kinetics assayed by fluorescence studies of drug efflux from suspended human KB8-5 cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Protein binding of anthraquinone glycosides, with special reference to adriamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Characterization of the cooperative cross-linking of doxorubicin N-hydroxysuccinimide ester derivatives to water soluble proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Non-Stokesian nature of transverse diffusion within human red cell membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Structural basis of anthracycline selectivity for unilamellar phosphatidylcholine vesicles: an equilibrium binding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

The overall partitioning of anthracyclines into phosphatidyl-containing model membranes depends neither on the drug charge nor the presence of anionic phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Kinetics of bilirubin transfer between serum albumin and membrane vesicles. Insight into the mechanism of organic anion delivery to the hepatocyte plasma membrane

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Fatty acid flip-flop in phospholipid bilayers is extremely fast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

Self-association of doxorubicin and related compounds in aqueous solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/S0006-2952(98)00255-X

10.1016/S0006-2952(98)00255-X

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference